Acadian Asset Management
TVTX icon

Acadian Asset Management’s Travere Therapeutics TVTX Stock Holding History

Acadian Asset Management’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$510K Buy
9,007
+6,383
+243% +$283K ﹤0.01% 1439
2026
Q1 		$77K Sell
2,624
-26,186
-91% -$783K ﹤0.01% 1799
2025
Q4 		$1.1M Buy
+28,810
New +$937K ﹤0.01% 1099
2024
Q4 		– Sell
-16,452
Closed -$230K – 2173
2024
Q3 		$230K Sell
16,452
-128,449
-89% -$1.34M ﹤0.01% 1315
2024
Q2 		$1.19M Buy
144,901
+97,020
+203% +$653K ﹤0.01% 939
2024
Q1 		$368K Buy
+47,881
New +$404K ﹤0.01% 1075
2020
Q3 		– Sell
-9,674
Closed -$198K – 2357
2020
Q2 		$198K Sell
9,674
-12,954
-57% -$206K ﹤0.01% 1491
2020
Q1 		$331K Sell
22,628
-11,945
-35% -$180K ﹤0.01% 1067
2019
Q4 		$491K Buy
+34,573
New +$442K ﹤0.01% 1075
2018
Q3 		– Sell
-29,418
Closed -$801K – 1795
2018
Q2 		$801K Buy
+29,418
New +$783K ﹤0.01% 790
2015
Q4 		– Sell
-496
Closed -$10K – 1508
2015
Q3 		$10K Sell
496
-88,993
-99% -$2.64M ﹤0.01% 1134
2015
Q2 		$2.97M Buy
+89,489
New +$2.45M 0.01% 508

Other funds holding TVTX

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Acadian Asset Management's TVTX Position: Q2 2026 in Review

Acadian Asset Management increased its Travere Therapeutics (TVTX) stake by 243% in Q2 2026, buying an estimated $283K and bringing the position to 9,007 shares worth $510K. The position accounts for ﹤0.01% of the portfolio, ranked #1439.

Acadian Asset Management first reported a position in TVTX in Q2 2015 and has held it in 12 quarters since. The position peaked at $2.97M in Q2 2015. 320 funds tracked by Wall St. Rank hold TVTX as of Q2 2026.

  • Acadian Asset Management held 9,007 shares of Travere Therapeutics worth $510K as of Q2 2026.
  • Acadian Asset Management bought 6,383 Travere Therapeutics shares in Q2 2026, an estimated $283K.
  • Travere Therapeutics made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #1439 holding.
  • Acadian Asset Management first reported a position in Travere Therapeutics in Q2 2015 and has held it in 12 quarters since.
  • Acadian Asset Management's Travere Therapeutics position peaked at $2.97M in Q2 2015.
  • 320 funds tracked by Wall St. Rank held Travere Therapeutics as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.